🌎 Duolingo Downgraded, Webull Initiated, Entergy Initiated and more…

Ratings changes for Duolingo, Neonode, Webull, Dare Bioscience, Biogen, The Hackett Group, Privia Health Group and more…Upgrade to MarketBeat All Access to get our best stock ideas, proprietary research, portfolio monitoring tools, and more. Start Your Free Trial.

Unsubscribe.

VIEW MY PORTFOLIO

SEPTEMBER 4TH, 2025

AI Continues to Surge—Here Are 2 Stocks Still Under $15 (ad)

Markets are volatile—but AI keeps rising.

A new report reveals two under-the-radar AI stocks under $15 that could thrive in 2025’s uncertain market. These picks are backed by key trends most investors are missing.

DOWNLOAD YOUR FREE REPORT: 2 AI STOCKS UNDER $15 FOR 2025

Today’s Top Stories

Americans would save $100B if credit card rates were capped as Trump proposed, researchers say

BY THE ASSOCIATED PRESS | SEPTEMBER 4, 2025 08:25 AM

Will these 3 stocks overtake the infamous Mag 7? (Ad)

BY INVESTORPLACE

Applications for US jobless benefits rise but remain in a healthy range

BY THE ASSOCIATED PRESS | SEPTEMBER 4, 2025 07:39 AM

Wall Street inches higher before the bell ahead of critical jobs data release this week

BY THE ASSOCIATED PRESS | SEPTEMBER 3, 2025 11:26 PM

7 Tiny “Trump Stocks” Poised for Large Moves (Ad)

BY TRADINGTIPS

Alphabet Stock Surges After Dodging Harsh Antitrust Remedies

BY RYAN HASSON | SEPTEMBER 3, 2025 05:06 PM

Why Qualcomm Is Outperforming NVIDIA After Months of Lagging

BY SAM QUIRKE | SEPTEMBER 3, 2025 04:24 PM

Quick Links

Analyst Ratings My MarketBeat Account Settings MarketBeat All Access Stock Lists Stock Screener Calculators Premium Reports Best Stocks to Buy in September

Three Stocks for Trump’s Made in America Boom (ad)

Louis Navellier has spent more than 40 years using his proprietary stock rating system to uncover explosive winners — long before Wall Street caught on. His track record includes spotting Amazon, Apple, Microsoft, and Nvidia years ahead of their massive runs.

Now, he says three new stocks have just triggered his system’s strongest buy signal for 2025. Each is tied to America’s push to rebuild its industrial base and lead the next wave of AI innovation. Louis has detailed them in a special report, ReMade in America: 3 Stocks for Trump’s New Industrial Boom — available free of charge.

CLICK HERE NOW TO CLAIM YOUR FREE COPY OF LOUIS NAVELLIER’S REPORT

Your Watchlist

MANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO

Apple Inc. (AAPL)

$239.39 +0.92 (+0.39%) As of 9/4/2025 9:48 AM ET

Prediction: 2 Stocks That’ll Be Worth More Than Apple 3 Years From Now 9/4 – FOOL
Big Victory for Apple, Trump Reacts to “Unstoppable” China 9/4 – BENZINGA
When Warren Buffett Says to Buy an S&P 500 Index Fund, Is He Advocating Putting 20% of Your Investment Portfolio in Nvidia, Microsoft, and Apple? 9/4 – FOOL
Big Victory for Apple, Trump Reacts to “Unstoppable” China 9/4 – BENZINGA
Mediolanum International Funds Ltd Cuts Stock Holdings in Apple Inc. $AAPL9/4 – MARKETBEAT

Amazon.com, Inc. (AMZN)

$233.88 +7.89 (+3.49%) As of 9/4/2025 9:48 AM ET

Amazon (AMZN) Completes Axio Acquisition, Eyes Direct Loans to Indian Customers9/4 – TIPRANKS
JetBlue to enhance onboard Wi-Fi with Amazon’s Kuiper network by 2027 9/4 – REUTERS
JetBlue to boost in-flight Wi-Fi with Amazon Project Kuiper internet deal 9/4 – CNBC
Amazon’s Satellite Internet Venture Signs Up Its First Airline 9/4 – WSJ
Moms’ careers and personal time are hit hard by school drop-off demands, a poll finds9/4 – MARKETBEAT

Alphabet Inc. (GOOGL)

$227.55 -3.11 (-1.35%) As of 9/4/2025 9:48 AM ET

Alphabet (NASDAQ:GOOGL) had its price target raised by Canaccord Genuity Group Inc. ( ) (analyst Maria Ripps) from $230.00 to $270.00. They now have a “buy” rating on the stock. This represents a 17.1% upside from the current price of $230.66.
BW Gestao de Investimentos Ltda. Has $4.57 Million Stake in Alphabet Inc. $GOOGL9/4 – MARKETBEAT
Belmont Capital LLC Acquires 4,840 Shares of Alphabet Inc. $GOOGL 9/4 – MARKETBEAT
Retail investors use spike in Google parent share price to take profits 9/4 – MARKETWATCH
Alphabet’s stock climbs after judge rules Google won’t be forced to sell Chrome 9/4 – MSN
Alphabet Shares Jump on Favorable Antitrust Ruling. Can the Stock Keep Its Momentum or Is It Too Late to Buy? 9/4 – FOOL

Meta Platforms, Inc. (META)

$752.10 +15.05 (+2.04%) As of 9/4/2025 9:48 AM ET

Meta Platforms, Inc. $META is Bridgeway Capital Management LLC’s Largest Position9/4 – MARKETBEAT
Meta Platforms, Inc. $META Shares Sold by BW Gestao de Investimentos Ltda.9/4 – MARKETBEAT
Meta Platforms (NASDAQ: META) Stock Price Prediction for 2025: Where Will It Be in 1 Year (Sept 4) 9/4 – 247WALLST
Mixed options sentiment in Meta Platforms Inc with shares up 0.22% 9/3 – MSN
Meta Launches Instagram for iPad, Says Version for Android Tablets Coming Soon9/3 – PYMNTS

Microsoft Corporation (MSFT)

$504.82 -0.53 (-0.11%) As of 9/4/2025 9:48 AM ET

Microsoft gives U.S. GSA $6B savings for cloud services over 3 years, CNBC says 9/4 – MSN
Microsoft Corporation $MSFT Stock Position Increased by Nvwm LLC 9/4 – MARKETBEAT
Mediolanum International Funds Ltd Cuts Holdings in Microsoft Corporation $MSFT9/4 – MARKETBEAT
Microsoft: Computing Demand To Outpace Supply Until Year End 9/3 – SEEKINGALPHA
Microsoft (MSFT) Scored With Minecraft Movie: Is Call Of Duty The Next Box Office Hit?9/3 – BENZINGA

MANAGE YOUR WATCHLIST

Analysts’ Upgrades

Coherus Oncology (NASDAQ:CHRS) was upgraded by analysts at Maxim Group from a “hold” rating to a “buy” rating. They now have a $4.00 price target on the stock. This represents a 204.2% upside from the current price of $1.32.

Dare Bioscience (NASDAQ:DARE) was upgraded by analysts at Maxim Group from a “hold” rating to a “buy” rating. They now have a $8.00 price target on the stock. This represents a 273.8% upside from the current price of $2.14.

Airbus Group (OTCMKTS:EADSY) was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating.The current price is $53.67.

Brinker International (NYSE:EAT) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating. They now have a $210.00 price target on the stock, up previously from $190.00. This represents a 25.9% upside from the current price of $166.82.

VIEW MORE UPGRADES

7 High-Yield Dividend Stocks You Need to See (ad)

7 High Yield Dividend Stocks to Buy Now 💰

Love steady payouts? This free report reveals 7 high-yield dividend stocks you need to know about. From Company #3, a tobacco giant innovating with smokeless products, to Company #4, famously known as “The Monthly Dividend Company,” these picks deliver steady income you can count on.

PERFECT FOR INCOME-FOCUSED INVESTORS.

Analysts’ Downgrades

Duolingo (NASDAQ:DUOL) was downgraded by analysts at DA Davidson from a “buy” rating to a “neutral” rating. They now have a $300.00 price target on the stock, down previously from $500.00. This represents a 8.2% upside from the current price of $277.37.

Navient (NASDAQ:NAVI) was downgraded by analysts at Bank of America Corporation from a “neutral” rating to an “underperform” rating. They now have a $12.00 price target on the stock. This represents a 9.2% downside from the current price of $13.22.

Neonode (NASDAQ:NEON) was downgraded by analysts at LADENBURG THALM/SH SH from a “buy” rating to a “neutral” rating. They now have a $6.00 price target on the stock. This represents a 31.2% upside from the current price of $4.57.

Texas Roadhouse (NASDAQ:TXRH) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “in-line” rating. They now have a $190.00 price target on the stock. This represents a 11.6% upside from the current price of $170.25.

VIEW MORE DOWNGRADES

NVIDIA’s Worst Nightmare? (ad)

$2 TRILLION Quantum Gold Rush

While everyone fights over expensive AI stocks… McKinsey just revealed the REAL fortune they expect to come from quantum computing – a $2 trillion explosion by 2035. The kicker? One company is America’s FIRST commercial supplier of the material that makes it possible.

CLICK HERE TO LEARN HOW TO GET THE TICKER SYMBOL <<<

Analysts’ New Coverage

Arcturus Therapeutics (NASDAQ:ARCT) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $60.00 price target on the stock. This represents a 253.4% upside from the current price of $16.98.

Webull (NASDAQ:BULL) is now covered by analysts at Northland Securities. They set an “outperform” rating and a $18.00 price target on the stock. This represents a 37.9% upside from the current price of $13.05.

Entegris (NASDAQ:ENTG) is now covered by analysts at Oppenheimer Holdings, Inc.. They set a “market perform” rating and a $95.00 price target on the stock. This represents a 21.8% upside from the current price of $78.02.

Entergy (NYSE:ETR) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $109.00 price target on the stock. This represents a 22.4% upside from the current price of $89.05.

Figma (NYSE:FIG) is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $85.00 price target on the stock. This represents a 50.4% upside from the current price of $56.50.

HubSpot (NYSE:HUBS) is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $675.00 price target on the stock. This represents a 46.5% upside from the current price of $460.87.

IDEAYA Biosciences (NASDAQ:IDYA) is now covered by analysts at Citizens Jmp. They set an “outperform” rating and a $41.00 price target on the stock. This represents a 56.6% upside from the current price of $26.19.

Primoris Services (NASDAQ:PRIM) is now covered by analysts at Mizuho. They set a “neutral” rating and a $112.00 price target on the stock. This represents a 3.1% downside from the current price of $115.63.

Quanta Services (NYSE:PWR) is now covered by analysts at Mizuho. They set a “neutral” rating and a $360.00 price target on the stock. This represents a 3.6% downside from the current price of $373.50.

Syndax Pharmaceuticals (NASDAQ:SNDX) is now covered by analysts at Guggenheim. They set a “buy” rating and a $34.00 price target on the stock. This represents a 109.3% upside from the current price of $16.25.

ARS Pharmaceuticals (NASDAQ:SPRY) is now covered by analysts at Roth Capital. They set a “buy” rating and a $40.00 price target on the stock. This represents a 263.1% upside from the current price of $11.02.

TransMedics Group (NASDAQ:TMDX) is now covered by analysts at Stifel Nicolaus. They set a “hold” rating and a $115.00 price target on the stock. This represents a 10.2% upside from the current price of $104.39.

VIEW MORE NEW COVERAGE

Calendars from MarketBeat

Dividend Declarations

Earnings Announcements

Earnings Conference Calls

FDA Calendar

Gap Up/Down Stocks

Insider Trades

Initial Public Offerings (IPOs)

Most Active Stocks

Percentage Gainers/Decliners

Sector Performance

Short Interest

Stock Splits

Unusual Options Volume

Unusual Trading Volume

GET 30 DAYS OF MARKETBEAT ALL ACCESS FREE

Best-in-Class Portfolio Monitoring

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools

Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.

START YOUR 30-DAY FREE TRIAL

Why Trump’s 3-Step Turnaround Will Supercharge Your Portfolio

Score a New Pool with the D-backs and Presidential Pools!

RJ Hamster

🌎 Duolingo Downgraded, Webull Initiated, Entergy Initiated and more…

SEPTEMBER 4TH, 2025

AI Continues to Surge—Here Are 2 Stocks Still Under $15 (ad)

Today’s Top Stories

Quick Links

Three Stocks for Trump’s Made in America Boom (ad)

Your Watchlist

Analysts’ Upgrades

7 High-Yield Dividend Stocks You Need to See (ad)

Analysts’ Downgrades

NVIDIA’s Worst Nightmare? (ad)

Analysts’ New Coverage

Calendars from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Share this:

Like this:

Related articles